NICE rejects long-acting HIV prevention treatment lenacapavir for NHS use
The National Institute for Health and Care Excellence said that the cost-effectiveness estimates of lenacapavir were above what it deems...
National framework for hazardous medicines needed to protect workers, says pharmacy oncology group
The British Oncology Pharmacy Association has recommended pre-filled syringes and a 'transparent governance' process to improve the safe management of...
Danger ahead: the growing threat of fungal disease and antifungal resistance
As antifungal resistance becomes more common, researchers, clinicians and pharmacists are looking for innovative ways to stay ahead. From antifungal...
Exercise and wellbeing programme reduces side effects of prostate cancer treatment, study finds
There are now plans for the Cancer Activity Programme to be extended to breast and bowel cancer patients....
Manufacturers’ body reports £2bn boost to pharma investment in UK in the past year
The Association of the British Pharmaceutical Industry highlighted 16 financial commitments made by 13 pharmaceutical companies between October 2025 and...
International Pharmaceutical Federation calls for bigger role for pharmacists in prevention of substance use disorders
FIP said governments should remove unnecessary barriers to pharmacist provision of opioid antagonists, including naloxone....